Pain Awareness Month was established in 2001 by a coalition of 80 organizations, the Partners for Understanding Pain, led by ...

Intravenous ketamine may provide short-term analgesia for complex regional pain syndrome, but predictors of treatment success remain limited.

Hormonal treatments for endometriosis may lead to reduced bone mineral density in reproductive-aged women and people assigned ...

The FDA has approved Lisraya tablets to manage adult dermatomyositis, offering the first oral treatment for the disease in adults.

A recent guideline update details best practices for initiating and selecting pharmacologic migraine preventive therapies among adults.

The CDC launched a web page that compiles the United States' drug overdose numbers, prevention tips, and treatment resources.

Buprenorphine dispensing rates and long-term initiation and retention remained consistently higher in rural than in urban US counties.

Updated American Academy of Neurology and American Headache Society guidelines address pharmacologic options for preventing adult migraines.

Adding cognitive behavioral therapy or a chronic pain self-management program to a patient-centered prescription opioid taper does not improve taper success at 12 months.

Patients with advanced knee osteoarthritis may see similar benefits from robotically assisted total knee replacement vs conventional tools.

Effective pain management may help prevent suicidal ideation among US service members and veterans experiencing pain interference.

A pilot study evaluated the I-STRONG program, a virtual multicomponent intervention, for managing chronic pain in SCD.